Sitagliptin and metformin hydrochloride

(Janumet®)

Sitagliptin and metformin hydrochloride

Drug updated on 11/17/2023

Dosage FormTablet (oral; sitagliptin/metformin hydrochloride 50 mg/500 mg) Tablet (oral; sitagliptin/metformin hydrochloride 50 mg/1000 mg)
Drug ClassMultiple
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.